Login / Signup

Management and Long-term Outcomes of Crohn's Disease Complicated with Enterocutaneous Fistula: ECUFIT Study from GETECCU.

Manuel Barreiro-de AcostaSabino RiestraMargalida CalafatMaría Pilar SotoMarta CalvoEugenia Sánchez RodríguezBerta CaballolMilagros VelaMontserrat RiveroFernando MuñozLuisa de CastroXavier CalvetFrancisco Javier García-AlonsoAlejandra Utrilla FornalsRocio Ferreiro-IglesiasCarlos González-MuñozaMaria ChaparroLuis BujandaBeatriz SiciliaErika AlfambraAndrés RodríguezRubén Pérez FernándezCristina RodríguezPedro AlmelaFederico ArgüellesDavid BusquetsSonsoles Tamarit-SebastiánCristina Reygosa CastroLaura JiménezIgnacio Marín-JiménezNoelia AlcaideEstela Fernández-SalgadoÁgueda IglesiasÁngel PonferradaRamón PajaresÓscar RonceroVíctor Jair Morales-AlvaradoNahia Ispízua-MadariagaEmpar SáinzOlga MerinoLucía Márquez-MosqueraMariana García-SepulcreAinara ElorzaSandra EstrechaGerard SurísManuel Van DomselaarAlicia BrotonsRuth de FranciscoFiorella CañeteEva IglesiasMaría Isabel VeraFrancisco MesoneroRufo LorenteYamile ZabanaJosé Luis CabriadaEugeni DomènechIago Rodriguez-Lago
Published in: Journal of Crohn's & colitis (2022)
ECF complicating CD are rare but entail a high burden of medical and surgical resources. Closure rates are high, usually after surgery, and fistula recurrence is uncommon. A significant proportion of patients receiving medical therapy can achieve fistula closure.
Keyphrases
  • healthcare
  • risk factors
  • mesenchymal stem cells
  • nk cells